Discussion document for the multistakeholders meeting on pharmaceuticals ( Meeting DG GROW 12th September 2017
…
Health policies in the EU aim to increase the healthy life expectancy of
…
https://www.inami.fgov.be/SiteCollectionDocuments/innovative_medicines_with_budgetary_limitations.docx
The use of real world data throughout
an innovative medicine’s lifecycle
…
The challenge for health policies is to provide high quality of care for all, within a sustainable health
…
https://www.inami.fgov.be/SiteCollectionDocuments/real_world_data.docx
string;#01-11-2003 - Circulaire MRPA MRS 2003/11
…
https://www.inami.fgov.be/SiteCollectionDocuments/circulaires_mrpa_mrs_2003_11.pdf
string;#2004.03.1 Circulaire MRPA MRS 2004/03 CSJ 2004/01
https://www.inami.fgov.be/SiteCollectionDocuments/circulaires_mrpa_mrs_2004_03_csj_2004_01.pdf
Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières Groep ter Opsporing, Studie en Preventie van Infecties in de Ziekenhuizen asbl-vzw
…
M M E E S S U U R
…
https://www.inami.fgov.be/SiteCollectionDocuments/circulaires_mrpa_mrs_2008_03_annexe03.pdf
string;#01-06-2002 - Circulaire MRPA MRS-CSJ 2002/06
…
https://www.inami.fgov.be/SiteCollectionDocuments/circulaires_mrpa_mrs_csj_2002_06.pdf
“Dure” geneesmiddelen - nominatieve lijst van de geneesmiddelenklassen, overeen gekomen in de overeenkomstencommissie - Derogatie op de tarifering per eenheid per week toegelaten
…
https://www.inami.fgov.be/SiteCollectionDocuments/lijst_nominatieve_TPE_geneesmiddelen.pdf
M.O.R.S.E sem integr report 2008 (2) – data 2nd semester 2008 DEPARTMENT OF MEDICAL CARE – MORSE project Page 1 of 48 Monitoring Of Reimbursement Significant Expenses
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2008-second-semester.pdf
9$;
$
: I + <
$ $
$
? <
$
: A : F J D I
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2009.pdf
B A ! 9
9 C ’ 9A ! B
A
D
A A "
D D A
B *A %% E BA A
D A
! "
A
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2010.pdf
OVERVIEW OF GLOBAL EXPENDITURE ON PHARMACEUTICAL SPECIALTIES, BROKEN DOWN INTO PUBLIC PHARMACIES AND HOSPITALS
…
EXPENDITURE ON MEDICINES IN HOSPITALS: BREAKDOWN BY TYPE OF PATIENT
…
https://www.inami.fgov.be/SiteCollectionDocuments/morse-report-2019.pdf
string;#01-11-2003 - Omzendbrief ROB RVT 2003/11
…
https://www.inami.fgov.be/SiteCollectionDocuments/omzendbrieven_rob_rvt_2003_11.pdf
string;#2004.03.1 Omzendbrief ROB RVT 2004/03 CDV 2004/01
https://www.inami.fgov.be/SiteCollectionDocuments/omzendbrieven_rob_rvt_2004_03_cdv_2004_01.pdf
PROTOCOL 3 Scientific evaluation of the 25 projects of the second call – implementation analysis 18 August 2017
…
Thérèse Van Durme Maja Lopez Hartmann Sibyl Anthierens
…
https://www.inami.fgov.be/SiteCollectionDocuments/scientific_repport_protocol3_01.pdf
Data collection for the two control groups used
…
Stratification based on the disability profile
…
Stratification based on the historic healthcare consumption
…
Cost evaluation of the change of
…
https://www.inami.fgov.be/SiteCollectionDocuments/scientific_repport_protocol3_02.pdf